Search

Displaying results 641 - 650 of 10000 in total
  1. Drug

    Granisetron

    go.drugbank.com/drugs/DB00889
    ApprovedInvestigational

    A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients.

    Categories: Alimentary Tract and Metabolism, Antiemetics and AntinauseantsProducts: KEVATRIL 2MG, GRANISETRON BETA 2MG
  2. Drug

    Sumatriptan

    go.drugbank.com/drugs/DB00669
    ApprovedInvestigational

    Sumatriptan is a serotonin receptor agonist commonly used to treat migraines and sometimes cluster headaches. … [L6793,L6796,L6799,L6805,L6808,L6811] Sumatriptan is the first of the triptans and was made available in Europe in 1991 to treat migraines.

    Mixtures: Sumatriptan and Naproxen Sodium, Sumatriptan and Naproxen SodiumCategories: sumatriptan and naproxen, Genito Urinary System and Sex Hormones
  3. Drug

    Alpelisib

    go.drugbank.com/drugs/DB12015
    ApprovedInvestigational

    , differentiation, and metabolism. … Alpelisib is marketed under the trade name Piqray and is available as oral tablets.

    Categories: Antineoplastic and Immunomodulating AgentsProducts: PIQRAY 250MG DAILY DOSE PACK (200mg + 50mg), PIQRAY 300MG DAILY DOSE PACK (150mg + 150mg)
  4. Drug

    Ibandronate

    go.drugbank.com/drugs/DB00710
    ApprovedInvestigational

    Ibandronate, or BM 21.0955, is a third generation, nitrogen containing bisphosphonate similar to [zoledronic acid], [minodronic acid], and [risedronic acid]. … [A203111,A203138] It is used to prevent and treat postmenopausal osteoporosis.[L13805,L13808] Ibandronate was first described in the literature in 1993 as a treatment for bone loss in dogs.

    Categories: ibandronic acid and colecalciferol, Drugs Affecting Bone Structure and MineralizationProducts: BONDRONAT 2MG, IBANDRONSAEURE AL 2MG
  5. Drug

    Aluminum sulfate

    go.drugbank.com/drugs/DB11239
    Approved

    By overcoming the body barriers, Al may infiltrate into the blood and lead to toxic effects in liver, bone and the central nervous system [L2145]. … Al is found in materials used in the pharmaceutical industry, and in manufactured foodstuffs, cosmetics, and tap water.

    Products: Rastringent II 250mg/ml, Gingi-Aid MAX Z-Twist 1
  6. Drug

    Sitagliptin

    go.drugbank.com/drugs/DB01261
    ApprovedInvestigational

    Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus[FDA label,A2260,A2255,A2256 … The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar[FDA label,A2255].

    Mixtures: Steglujan (Ertugliflozin 15mg/Sitagliptin 100mg) Film-Coated Tablets, Steglujan (Ertugliflozin 5mg/Sitagliptin 100mg) Film-Coated TabletsCategories: Alimentary Tract and Metabolism, metformin and sitagliptin
  7. Drug

    Dobutamine

    go.drugbank.com/drugs/DB00841
    ApprovedInvestigational

    A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.

    Categories: Adrenergic and Dopaminergic AgentsProducts: INOTROP (Dobutamine HCl 25mg/ml Concentrate for Solution for Infusion), DOBUTHAVER 250MG/20ML IV INFÜZYON IÇIN KONSANTRE ÇÖZELTI IÇEREN AMPUL ,10 AMPUL
  8. Drug

    Afoxolaner

    go.drugbank.com/drugs/DB11369
    ExperimentalVet approved

    Mixtures: Nexgard Spectra 75mg/15mg Chewable Tablets for Dogs >15-30kg, Nexgard Spectra 9mg/2mg Chewable Tablets for Dogs 2-3.5kgProducts: NexGard 28mg chewable tablets for dog > 4-10kg, NexGard 68mg chewable tablets for dogs > 10-25kg
  9. Drug

    Pancuronium

    go.drugbank.com/drugs/DB01337
    Approved

    As a neuromuscular blocking agent it is more potent than curare but has less effect on the circulatory system and on histamine release.

    Products: Pavulon Inj 2mg/ml, Pavulon Inj 1mg/ml
  10. Drug

    Ceftazidime

    go.drugbank.com/drugs/DB00438
    ApprovedInvestigational

    [L32935] Ceftazidime was approved by the FDA on July 19, 1985, and is currently available either alone or in combination with the non-β-lactam β-lactamase inhibitor [avibactam] to treat a variety of … Bacteria possess a cell wall comprising a glycopeptide polymer commonly known as peptidoglycan, which is synthesized and remodelled through the action of a family of enzymes known as "penicillin-binding

    Products: Ceftazidime and Dextrose, Ceptaz Inj 10gm/vial